No data are available about the amount of hepatitis B virus (HBV) genomes in liver of patients with chronic HBV infection. The aim of this study was to quantify the intrahepatic HBV DNA in hepatitis B surface antigen (HBsAg)-positive patients with either active or suppressed viral replication and in
Polymorphism of Precore Region of Hepatitis B Virus DNA among Patients with Chronic HBV Infection in Turkey
✍ Scribed by A.M. Bozdayi; H. Bozkaya; A. Türkyilmaz; N. Aslan; H. Verdi; A. Kence; Ö. Uzunalimoglu
- Book ID
- 107706033
- Publisher
- Springer-Verlag
- Year
- 1999
- Tongue
- English
- Weight
- 90 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0300-8126
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ؍ 60
## Abstract Variants in the amino acid composition of the primary antibody‐binding site of hepatitis B surface antigen (HBsAg) have been identified in a number of populations with chronic hepatitis B virus (HBV) infection. Direct sequencing of amplified or cloned PCR products, solid phase detection